PYC held a webinar a couple of weeks ago for the Phelan McDermid community. The initiative was in conjunction with the Phelan McDermid Syndrome Foundation, which is the largest PMS community in the world.
In the webinar, the RNA approach being used by PYC to treat the condition is explained and an update is provided on progress in the PYC-002 development program.
A link to the webinar can be found below. Duration is ~17mins.
https://pmsf.org/pyc-therapeutics-webinar-takeaways/
Ann: PYC Nominates Fourth Clinical Drug Candidate in PMS Program, page-18
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.16 |
Change
-0.025(2.11%) |
Mkt cap ! $676.5M | |||
| Open | High | Low | Value | Volume |
| $1.19 | $1.20 | $1.16 | $45.30K | 38.23K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 4346 | $1.16 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.19 | 563 | 1 |
View Market Depth
| Last trade - 16.10pm 16/06/2025 (20 minute delay) ? |
| PYC (ASX) Chart |